Literature DB >> 35034687

Usefulness of self-administered questionnaires in screening for direct referral for polysomnography without sleep physician review.

Craig Hukins1, Brett Duce1.   

Abstract

STUDY
OBJECTIVES: To evaluate self-administered screening questionnaires (Epworth Sleepiness Scale [ESS], Berlin, OSA50, and STOP-Bang questionnaires) in patients considered for polysomnography for probable obstructive sleep apnea suitable for direct polysomnography without sleep specialist review and to evaluate the usefulness of combining questionnaires in this population.
METHODS: This was a retrospective review of tertiary sleep center referrals (November 2017 to April 2020) where ≥ 3 screening questionnaires were completed and type 1 polysomnography was performed. Sensitivity, specificity, positive and negative predictive values, and likelihood ratios to detect an apnea-hypopnea index (AHI) ≥ 15 or ≥ 30 events/h were calculated for each questionnaire (with or without ESS ≥ 8) or any positive questionnaire with ESS ≥ 8.
RESULTS: We included 2,152 patients. The questionnaires were completed in the majority (ESS 96%, Berlin 77%, OSA50 84%, and STOP-Bang 90%) of referrals. Berlin was most sensitive (82.5% and 85% to detect AHI ≥ 15 and ≥ 30 events/h, respectively) but least specific (23% both thresholds). STOP-Bang was least sensitive (66% and 42%, respectively) but most specific (68% and 60%, respectively). Sensitivity declined for the Berlin, OSA50 and STOP-Bang questionnaires when combined with ESS ≥ 8. Combining any questionnaire with ESS ≥ 8 returned an intermediate sensitivity of 61% and 73% and a specificity of 49% and 47% for AHI ≥ 15 and ≥ 30 events/h, respectively. STOP-Bang alone was predictive of obstructive sleep apnea on multivariate analysis but was only associated with a clinically nonsignificant positive likelihood ratio. However, STOP-Bang is associated with unacceptable false-positive and -negative rates, which did not support its use.
CONCLUSIONS: Self-administered questionnaires are inadequate in patients under consideration for polysomnography and should not be used as clinical support for suitability of direct polysomnography without sleep specialist review. Combining questionnaires causes deteriorated performance. CITATION: Hukins C, Duce B. Usefulness of self-administered questionnaires in screening for direct referral for polysomnography without sleep physician review. J Clin Sleep Med. 2022;18(5):1405-1412.
© 2022 American Academy of Sleep Medicine.

Entities:  

Keywords:  OSA; obstructive sleep apnea; polysomnography; screening questionnaires

Mesh:

Year:  2022        PMID: 35034687      PMCID: PMC9059604          DOI: 10.5664/jcsm.9876

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.324


  16 in total

Review 1.  A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis.

Authors:  Joachim E Fischer; Lucas M Bachmann; Roman Jaeschke
Journal:  Intensive Care Med       Date:  2003-05-07       Impact factor: 17.440

2.  A simplified model of screening questionnaire and home monitoring for obstructive sleep apnoea in primary care.

Authors:  Ching Li Chai-Coetzer; Nick A Antic; L Sharn Rowland; Peter G Catcheside; Adrian Esterman; Richard L Reed; Helena Williams; Sandra Dunn; R Doug McEvoy
Journal:  Thorax       Date:  2011-01-20       Impact factor: 9.139

3.  Prospective study of the association between sleep-disordered breathing and hypertension.

Authors:  P E Peppard; T Young; M Palta; J Skatrud
Journal:  N Engl J Med       Date:  2000-05-11       Impact factor: 91.245

4.  Association of sleep-disordered breathing and the occurrence of stroke.

Authors:  Michael Arzt; Terry Young; Laurel Finn; James B Skatrud; T Douglas Bradley
Journal:  Am J Respir Crit Care Med       Date:  2005-09-01       Impact factor: 21.405

5.  Detecting sleep apnoea syndrome in primary care with screening questionnaires and the Epworth sleepiness scale.

Authors:  Chamara V Senaratna; Jennifer L Perret; Adrian Lowe; Gayan Bowatte; Michael J Abramson; Bruce Thompson; Caroline Lodge; Melissa Russell; Garun S Hamilton; Shyamali C Dharmage
Journal:  Med J Aust       Date:  2019-05-03       Impact factor: 7.738

6.  Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine.

Authors:  Richard B Berry; Rohit Budhiraja; Daniel J Gottlieb; David Gozal; Conrad Iber; Vishesh K Kapur; Carole L Marcus; Reena Mehra; Sairam Parthasarathy; Stuart F Quan; Susan Redline; Kingman P Strohl; Sally L Davidson Ward; Michelle M Tangredi
Journal:  J Clin Sleep Med       Date:  2012-10-15       Impact factor: 4.062

7.  High STOP-Bang score indicates a high probability of obstructive sleep apnoea.

Authors:  F Chung; R Subramanyam; P Liao; E Sasaki; C Shapiro; Y Sun
Journal:  Br J Anaesth       Date:  2012-03-08       Impact factor: 9.166

8.  Sleep-disordered breathing and mortality: a prospective cohort study.

Authors:  Naresh M Punjabi; Brian S Caffo; James L Goodwin; Daniel J Gottlieb; Anne B Newman; George T O'Connor; David M Rapoport; Susan Redline; Helaine E Resnick; John A Robbins; Eyal Shahar; Mark L Unruh; Jonathan M Samet
Journal:  PLoS Med       Date:  2009-08-18       Impact factor: 11.069

9.  Diagnostic performance of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnea in different ethnic groups.

Authors:  Rida Waseem; Matthew T V Chan; Chew Yin Wang; Edwin Seet; Stanley Tam; Su Yin Loo; Carmen K M Lam; David S Hui; Frances Chung
Journal:  J Clin Sleep Med       Date:  2021-03-01       Impact factor: 4.062

10.  Validation of the STOP-Bang questionnaire for screening of obstructive sleep apnea in the general population and commercial drivers: a systematic review and meta-analysis.

Authors:  Lina Chen; Bianca Pivetta; Mahesh Nagappa; Aparna Saripella; Sazzadul Islam; Marina Englesakis; Frances Chung
Journal:  Sleep Breath       Date:  2021-01-28       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.